Supiot S, Doré M, Rio E
Département de radiothérapie, Institut de cancérologie de l'Ouest, centre René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France.
Département de radiothérapie, Institut de cancérologie de l'Ouest, centre René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France.
Cancer Radiother. 2017 Oct;21(6-7):495-497. doi: 10.1016/j.canrad.2017.07.017. Epub 2017 Aug 25.
The Oligopelvis 2 studies is based on the assumption that salvage pelvic radiotherapy may prolong the interval between the first and the second intermittent hormone therapy sequence in pelvic lymph node oligometastatic prostate cancer. This phase 3 study will compare intermittent hormone therapy (standard arm) alone or combined with salvage pelvic radiotherapy (experimental arm).
寡转移骨盆2研究基于这样一种假设，即挽救性盆腔放疗可能会延长盆腔淋巴结寡转移前列腺癌首次和第二次间歇性激素治疗疗程之间的间隔时间。这项3期研究将比较单纯间歇性激素治疗（标准组）或联合挽救性盆腔放疗（试验组）的效果。
